Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin plus captopril versus diazepam plus captopril for hypertensive emergency
IRCT20260612069761N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertensive emergency comparing Intravenous nitroglycerin plus captopril with Slow intravenous diazepam plus captopril (2 arms). Primary endpoints: Reduction in systolic blood pressure, Reduction in diastolic blood pressure and 2 more. Started Sep 2026; status: completed.
02
Drugs
nitroglycerindiazepamcaptopril
03
Conditions
hypertensive emergency
Beyond the preview
Go deeper on IRCT20260612069761N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260612069761N1.